Little Susan E
Department of Veterinary Pathobiology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK 74078-2007, USA.
Vet Clin North Am Small Anim Pract. 2010 Nov;40(6):1121-40. doi: 10.1016/j.cvsm.2010.07.004.
In the time since canine ehrlichiosis due to Ehrlichia canis was first described in 1935 and first recognized in the United States in 1962, many key advances have been made in our understanding of the diversity of the rickettsial organisms responsible for ehrlichiosis and anaplasmosis in dogs and, occasionally, cats, the vectors capable of transmitting these agents, and the role these organisms play as both important veterinary pathogens and zoonotic disease agents. Despite considerable progress in the field, much remains to be learned regarding mechanisms contributing to pathogenesis, effective treatment modalities, and prevention strategies that best protect pet health. This article highlights current understanding of the transmission, diagnosis, and management of ehrlichiosis and anaplasmosis in dogs and cats.
自1935年首次描述犬埃立克体病（由犬埃立克体引起）并于1962年在美国首次确认以来，在我们对引起犬类（偶尔也包括猫）埃立克体病和无形体病的立克次体生物多样性、能够传播这些病原体的媒介以及这些生物作为重要兽医病原体和人畜共患病病原体所起的作用的理解方面取得了许多关键进展。尽管该领域取得了相当大的进展，但在导致发病机制的因素、有效的治疗方式以及最能保护宠物健康的预防策略方面仍有许多有待了解的地方。本文重点介绍了目前对犬猫埃立克体病和无形体病的传播、诊断和管理的理解。
